MW
Therapeutic Areas
Boundless Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| BBI-355 | Oncogene-amplified solid tumors | Phase 1 |
Leadership Team at Boundless Bio
ZH
Zachary Hornby
CEO, President, and Director
CH
Chris Hassig, Ph.D.
Chief Scientific Officer
DR
Dr. Robert Doebele, M.D., Ph.D.
Chief Medical Officer
JO
Jessica Oien
Chief Legal Officer
DH
David Hinkle
Senior Vice President, Finance & Controller
AB
Amy Berkley, Ph.D.
Senior Vice President, Program Team Leadership
AP
Angela Pietrofeso
Vice President, Clinical Operations
JL
Jonathan Lim, M.D.
Chairman and Co-Founder
J"
James "Jamie" Christensen, Ph.D.
Director
NW
Nancy Whiting, Pharm.D.
Director